Pharmaceutical Firm ARTEC, Inc.™ Announces Production of TUBERCIN™ for Selected Uses in South Africa and the Bahamas

Pharmaceutical Firm ARTEC, Inc.™ Announces Production of TUBERCIN™ for Selected Uses in South Africa and the Bahamas - Shareholders Follow-Up Report

Business Wire - November 26, 2007

OKLAHOMA CITY -- Production of TUBERCIN™, a revolutionary polysaccharide compound to be used as an HIV/AIDS and ANTI-CANCER immunostimulant, has begun with the focus on South Africa and the Bahamas as mission delivery sites, announces Mr. Gerry Knight, Executive Vice President of ARTEC, Inc.™ (Pink Sheets:ATKJ). ARTEC, Inc.™ has recently received the final plan for the testing on HIV/AIDS and Tuberculosis Patients in South Africa and anticipates in starting the testing process in early 2008.

Mr. Rodney Watson, ARTEC, Inc.™ South African Coordinator, is working on the details and logistics. More detailed information will be made available in future progress reports as soon as confidential aspects can be revealed. However, eminent scientists are currently working on producing the TUBERCIN™ powder which is the mainstay of production.

ARTEC, Inc.™ anticipates utilizing a product based on TUBERCIN™ to treat Patients in a Wellness Center environment. Mr. Cecil Thompson, ARTEC, Inc.™ Coordinator for Bahamas, is working closely with the company to carry out this project which will begin in 2008. ARTEC, Inc.™ has designated the Bahamas as the initial site for the Wellness Centers - a resort setting utilizing TUBERCIN™ and other health related products to promote good health. Later, the company will consider franchise and/or owner relationships to establish Wellness Centers in resort settings around the world.

Health care costs have recently become an issue for large membership Health Plans. Because cost savings can be realized off-shore by these companies, ARTEC, Inc.™ has been in discussions concerning the economic feasibility of treating select cases at the Wellness treatment center. Such treatment in pleasant and private surroundings will not dilute expert medical care, but may allow a reduced cost overhead.

To effectively distribute TUBERCIN™, ARTEC, Inc.™ has forged working relationships with a network of public advertising and Internet consultants. TUBERCIN™ is not a one-dimensional product. We believe it has the fundamental potential, from preventative, cosmetic, and pain-reduction perspectives, to facilitate good health world-wide.

The company will also work with a humanitarian foundation, and later with missionary groups, to bring TUBERCIN™ to those who can least afford to purchase TUBERCIN™ products. President Dr. Ronald Shinn believes that people who desperately need help should not be denied access because of poverty.

ARTEC, Inc.™ will release further information on the progress of product developments and integration at a later time. For more information on ARTEC, Inc.™ visit www.artec-inc.net.

Forward-Looking Statements

The Company cautions the investors that forward-looking statements in this press release involve risks and uncertainties pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. In addition, the company cautions investors that it undertakes no obligations or responsibilities to publicly update these forward-looking statements to reflect the Company's expectation with regard to these forward-looking statements or the occurrence of unanticipated events.

Contacts:

ARTEC, Inc.™ | Gerry Knight, 405-949-1808 | www.artec-inc.net

071126
BW071126

Copyright © 2007 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .